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Background
Many structural elements of HIV-1 gp120 have been
revealed by X-ray crystallography, NMR and electron
microscopy; however, several key immunogenic regions
are still not well understood. Data from the recent
RV144 trial indicated that antibodies targeting the V1V2
region correlate with a lower risk of infection. A detailed
characterization of anti-V2 antibodies, in concert with
recent V1V2 structural information is critical to the
design of a V2 immunogen.
Methods
We have determined a crystal structure of the uncom-
plexed Fab fragment of anti-V2 mAb 2158. To understand
the antigen binding mode of mAb 2158, we computation-
ally created twenty V1V2 models from a panel of gp120s
that were tested previously in ELISA for binding reactivity
with mAb 2158. Subsequently, we docked these models in
silico to the antigen binding site of mAb 2158.
Results
The structure of Fab 2158 revealed that its antigen binding
site consists of a hydrophobic surface comprised with resi-
dues from CDRs H2 and H3 with a deep pocket between
CDRs H1 and H3. Surface energy analysis suggests that
the heavy chain and the binding pocket are likely to dictate
the antigen binding mode of Fab 2158. Our model-build-
ing of the 20 V1V2 structures revealed that the residues
previously suggested as the mAb 2158 epitope all mapped
to a single face on the V2 domain next to glycosylation
site N186. Correlating our computational analysis with
ELISA data suggests that the glycosylation of N186 plays a
key role in binding and our docking results indicates that
the mAb 2158 binding pocket can accommodate the man-
nose glycan harbored by N186.
Conclusion
Structural analyses of Fab 2158 suggest that binding to a
conformational epitope containing an N-linked glycan.
Our results allow us to hypothesize a binding motif signa-
ture for anti-V2 mAb 2158 and form a framework for
designing V2 immunogens.
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